Hyperliquid introduced HIP-4, a platform for permissionless outcome trading. Currently, the trading tools are in the testnet stage, but the goal is a permissionlessHyperliquid introduced HIP-4, a platform for permissionless outcome trading. Currently, the trading tools are in the testnet stage, but the goal is a permissionless

Hyperliquid launches HIP-4 to expand into outcome and prediction trading

3 min read

Hyperliquid introduced HIP-4, a new platform for outcome trading. With this addition, HyperCore will support another trading mode, expanding overall activity. 

HyperCore will introduce HIP-4, enabling outcome trading. With this move, Hyperliquid will become a platform for options and predictions, building a new market beyond perpetual futures trading. 

Outcomes will be fully collateralized and will settle within a fixed range, remaining less risky compared to perpetual futures leveraged trading. The platform will offer general-purpose primitives, which will be available for apps to create new prediction markets and options instruments, announced the Hyperliquid team.

HIP-4 introduces third-party outcome markets

HIP-4 will become another builder-driven platform, seeking novel applications for HyprCore’s trading technology. The previous performance of HIP-3 has shown that builders can react within days, tapping highly active markets. HIP-3 only took days to offer silver and gold trading, becoming one of the most liquid markets for on-chain metal contracts. 

HIP-4 will bring dated contracts, as well as derivative trading without leverage or liquidations, unlike the other margin trading markets. 

The outcomes technology is still in the testnet stage, and the live markets will be deployed after testing is completed. Hyperliquid will settle the outcome markets in its native stablecoin, USDH. Native Markets, the issuer of USDH, announces the usage of the native stablecoin.

At the end stage, the platform will allow permissionless deployment for new outcome pairs. 

With this move, HyperEVM will become the next chain to host a potentially lively prediction market. This time, Hyperliquid is behind the trend, while other networks already host some of the leading prediction markets. 

Is crypto activity shifting to Hyperliquid?

Hyperliquid built up significant market depth and even became a competitor to Binance’s trading volumes. The biggest problem for the platform is liquidations, which erase open interest. 

Following the latest market downturn, as of February 2, Hyperliquid carried just $1.77B in BTC open interest and $4.97B in total open interest. Despite the outflows, HIP-3 continued growing, with over $1B in open interest and $4.8B in trading activity. 

Hyperliquid may be preferable due to its transparent markets and fewer signs of deliberate manipulation. The markets have inherent volatility and are affected by whales, but some pairs have built robust liquidity.

Jeff Yan, CEO and co-founder of Hyperliquid, noted the platform must remain neutral. 

The house of all finance must be credibly neutral. This means no private investors, no market maker deals, and no protocol fees to any company,’ wrote Yan in a recent post.

The shift to Hyperliquid happens as Binance and Wintermute had to defend themselves against accusations of orchestrating the October 11 market crash. 

Following the recent market activity, HYPE retained its recent gains, trading near its one-week highs of $32.12. $18.65M were poured into HYPE buybacks in the past week, for an average buyback price of $28.50.

If you're reading this, you’re already ahead. Stay there with our newsletter.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge

The surge follows a difficult August, when investors pulled out more than $750 million while rotating capital into Ethereum-focused funds. […] The post Bitcoin ETFs Outpace Ethereum With $2.9B Weekly Surge appeared first on Coindoo.
Share
Coindoo2025/09/18 01:15
CME Group to launch options on XRP and SOL futures

CME Group to launch options on XRP and SOL futures

The post CME Group to launch options on XRP and SOL futures appeared on BitcoinEthereumNews.com. CME Group will offer options based on the derivative markets on Solana (SOL) and XRP. The new markets will open on October 13, after regulatory approval.  CME Group will expand its crypto products with options on the futures markets of Solana (SOL) and XRP. The futures market will start on October 13, after regulatory review and approval.  The options will allow the trading of MicroSol, XRP, and MicroXRP futures, with expiry dates available every business day, monthly, and quarterly. The new products will be added to the existing BTC and ETH options markets. ‘The launch of these options contracts builds on the significant growth and increasing liquidity we have seen across our suite of Solana and XRP futures,’ said Giovanni Vicioso, CME Group Global Head of Cryptocurrency Products. The options contracts will have two main sizes, tracking the futures contracts. The new market will be suitable for sophisticated institutional traders, as well as active individual traders. The addition of options markets singles out XRP and SOL as liquid enough to offer the potential to bet on a market direction.  The options on futures arrive a few months after the launch of SOL futures. Both SOL and XRP had peak volumes in August, though XRP activity has slowed down in September. XRP and SOL options to tap both institutions and active traders Crypto options are one of the indicators of market attitudes, with XRP and SOL receiving a new way to gauge sentiment. The contracts will be supported by the Cumberland team.  ‘As one of the biggest liquidity providers in the ecosystem, the Cumberland team is excited to support CME Group’s continued expansion of crypto offerings,’ said Roman Makarov, Head of Cumberland Options Trading at DRW. ‘The launch of options on Solana and XRP futures is the latest example of the…
Share
BitcoinEthereumNews2025/09/18 00:56
The FDA Is Trying To Make Corporate Free Speech Situational

The FDA Is Trying To Make Corporate Free Speech Situational

The post The FDA Is Trying To Make Corporate Free Speech Situational appeared on BitcoinEthereumNews.com. BENSENVILLE, ILLINOIS – SEPTEMBER 10: Flanked by U.S. Attorney General Pam Bondi (rear), and FDA Commissioner Marty Makary (R), Secretary of Health and Human Services Robert F. Kennedy Jr. speaks to the press outside Midwest Distribution after it was raided by federal agents on September 10, 2025 in Bensenville, Illinois. According to the company, various e-liquids were seized in the raid. (Photo by Scott Olson/Getty Images) Getty Images While running for President in 2008, Barack Obama famously chanted “Yes we can.” Love or hate his political views, Obama’s politics were quite effective. He was asking voters to think big, to envision a much better future. Advertisers no doubt approved. That’s because ads routinely evoke things not as they are, but as they could be. Gyms and exercise equipment companies don’t promote their locations and equipment with flabby, lumbering people, rather their ads show fit, upright, energetic individuals. A look ahead. Restaurants do the same with ads showing happy people enjoying impressively put together plates of food. Conversely, ads meant to convince smokers to quit have not infrequently shown the worst of the worst future downsides of the habit. The nature of advertising comes to mind as FDA commissioner Marty Makary puzzlingly brags that “The Trump Administration Is Taking On Big Pharma” in the New York Times. Makary laments pharmaceutical ads that “are filled with dancing patients, glowing smiles and catch jingles that drown out the fine print.” Not explained is whether Makary would be happier if drug companies placed ads with immobile patients, frowns, and funereal music. Seriously, what does he expect? Does he want drug companies to commit billions to drug development to accompany their achievements with imagery defined by misery? Has Makary stopped to contemplate the myriad shareholders lawsuits drugmakers would face if, upon risking staggering sums meant…
Share
BitcoinEthereumNews2025/09/18 06:29